Regulatory Approvals

There may be multiple regulatory approvals required for any given research protocol. These may be driven by Institutional Review Board, department, school, center or research setting site requirements. Required approvals that may include:

UW Paul P Carbone Comprehensive Cancer Center - Protocol Review & Monitoring Committee
263-0169
Reviews all cancer-related research protocols

Cardiology Clinical Research Committee
263-4856
Reviews all Cardiology Section research protocols and provides consultation if needed on cardiac issues for protocols originating elsewhere

Institutional Biosafety Committee /Office of Biological Safety
263-9026
Reviews the research use of recombinant DNA and its derivatives

Radioactive Drug Research Committee
263-4856
Reviews research involving radiopharmaceuticals that do not deliver an intended clinical benefit or that are not FDA approved

William S Middleton Memorial Veterans Hospital (VA) - Research and Development Committee
256-1901, ext 7863 or 280-7007
Reviews all research protocols involving: 1) UW Health sciences researchers with paid appointments at the VA; 2) enrollment of subjects (including use of residual tissue and access to medical records) associated with the VA; or 3) use of VA facilities, e.g. space

University Wisconsin Hospital and Clinics - Research Safety Committee
263-8902
Reviews protocols possessing health hazards to UWHC employees, patients and/or environment, such as gene transfer studies and protocols intentionally exposing subjects to infectious agents

Meriter Hospital Institutional Review Board
267-6411